Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
Abdelhak, A.; Huss, A.; Stahmann, A.; Senel, M.; Krumbholz, M.; Kowarik, M. C. & Havla, J. et al. (2020)
Contemporary Clinical Trials Communications, 18 pp. 100574. DOI: https://doi.org/10.1016/j.conctc.2020.100574
Documents & Media
Details
- Authors
- Abdelhak, Ahmed; Huss, Andre; Stahmann, Alexander; Senel, Makbule; Krumbholz, Markus; Kowarik, Markus C.; Havla, Joachim; Kümpfel, Tania; Kleiter, Ingo; Wüstinger, Isabella; Tumani, Hayrettin
- Issue Date
- 2020
- Journal
- Contemporary Clinical Trials Communications
- ISSN
- 2451-8654
- Language
- English
- Sponsor
- http://dx.doi.org/10.13039/501100007458 German Multiple Sclerosis Society Federal Association
http://dx.doi.org/10.13039/100005614 Biogen
http://dx.doi.org/10.13039/100004334 Merck
http://dx.doi.org/10.13039/100004336 Novartis
http://dx.doi.org/10.13039/501100008977 University of Ulm
http://dx.doi.org/10.13039/100005614 Biogen
http://dx.doi.org/10.13039/100006436 Celgene
http://dx.doi.org/10.13039/100004334 Merck
http://dx.doi.org/10.13039/100004336 Novartis
http://dx.doi.org/10.13039/100004337 Roche
